Results 121 to 130 of about 51,689 (204)

Los medicamentos de alto precio en debate

Revista Médica del Uruguay, 2020
Danza, Álvaro, López, Maynés
openaire   +2 more sources

Protección de la Competencia en Chile: El Estado y Laboratorios Chile y Recalcine (1992-93) [PDF]

In 1992, Laboratorios Chile and Recalcine, the two largest pharmaceutical companies in Chile with a share of 82% of the domestic markets for generic products, were accused of collusion.
Edgardo Barandiarán, Ricardo Paredes
core  

Variability in public procurement prices for Group 1A drugs in the specialized pharmaceutical component: an observational study, 2013-2022. [PDF]

Epidemiol Serv Saude
Rossignoli P, Pontarolo R, Fernandez-Llimos F.   +2 more
europepmc   +1 more source

[Regulation of the online sale of medical products: experiences and strategies for Latin AmericaRegulamentação da venda de produtos médicos pela internet: experiências e estratégias para a América Latina]. [PDF]

Rev Panam Salud Publica, 2023
Rojas-Cortés R, Gorordo M, Vahos J, Galindo Wehdeking R, Saavedra H, Heredia A, Liévano D, Carino J, Sánchez MJ, Castro JL.   +9 more
europepmc   +1 more source

[HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare - insights from HEARTS in the AmericasQualidade da iniciativa HEARTS: marco de políticas para fortalecer o manejo da hipertensão e do risco cardiovascular na atenção primária à saúde. Perspectivas da iniciativa HEARTS nas Américas]. [PDF]

Rev Panam Salud Publica
Londoño E, Gupta R, Van der Stuyft P, Heine M, Giraldo G, Ku GM, Brettler J, Rosende A, Irazola V, Toelsie J, Neira C, Aumala T, Valdés Y, Zúñiga E, Rodríguez L, Villatoro M, Escobar MC, Pérez V, Bencomo A, Pereira M, de la Rosa A, Ordunez P.   +21 more
europepmc   +1 more source

Análisis y práctica de las políticas de precios y financiación de los medicamentos

, 2016
Con textos de F. Scott Morton, M. Kyfle y P.
openaire   +2 more sources

[Costs of pharmacological treatment in hypertension and type 2 diabetes mellitus]. [PDF]

Rev Med Inst Mex Seguro Soc
Figueroa-García J, Granados-García VM, Martínez-Barro D, Figueroa-Hernández MF, Palomo-Piñón S, Rojano-Mejía D.   +5 more
europepmc   +1 more source

[Cost-utility study of a high-resolution consultation (CARE-A) for the treatment of asthma exacerbations]. [PDF]

Open Respir Arch
Medina Gallardo JF, Maestre Sánchez MV, Muñoz Sánchez B, Ferrer Galván M, Romero Falcón A, León Lloreda A, Álvarez Gutiérrez FJ.   +6 more
europepmc   +1 more source

[Access to orphan drugs for the treatment of spinal muscular atrophy in Spain]. [PDF]

Rev Neurol, 2022
García-Parra B, Guiu JM, Modamio P, Martínez-Yélamos A, Mariño-Hernández EL, Povedano M.   +5 more
europepmc   +1 more source

[Drug shortages in Family Medicine practice]. [PDF]

Aten Primaria
Esteban-Jiménez Ó, Hernández-Rodríguez MÁ.   +1 more
europepmc   +1 more source